Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vibeke Strand

Showing results (411-420 of 436) with videos related to

Pageof 44
Sort By:
Journal of Drugs in Dermatology : JDD|December 2, 2025
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual MeetingSarah Romanelli, Gretchen D Ball, Arianna J Zhang, et al.
Seminars in Arthritis and Rheumatism|April 20, 2021
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods studySabrina Mai Nielsen, Maarten Boers, Maarten de Wit, et al.
The Journal of Rheumatology|March 18, 2014
Updating the OMERACT filter: core areas as a basis for defining core outcome setsJohn R Kirwan, Maarten Boers, Sarah Hewlett, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual MeetingArianna J Zhang, Gretchen Ball, Melissa P Zundell, et al.
The Journal of Rheumatology|March 4, 2014
Updating the OMERACT filter: implications for imaging and soluble biomarkersMaria-Antonietta D'Agostino, Maarten Boers, John Kirwan, et al.
The Journal of Rheumatology|February 17, 2019
Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA WorkshopEsi M Morgan, Jane E Munro, Jennifer Horonjeff, et al.
The Journal of Rheumatology|July 18, 2008
Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapyJorge Sánchez-Guerrero, Hilda E Fragoso-Loyo, C Michael Neuwelt, et al.
Pain|April 9, 2016
Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT systemShannon M Smith, Dagmar Amtmann, Robert L Askew, et al.
The Journal of Rheumatology|October 6, 2005
Minimal disease activity for rheumatoid arthritis: a preliminary definitionGeorge A Wells, Maarten Boers, Beverley Shea, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinementDorthe B Berthelsen, Ben Horgan, Lee Simon, et al.
Pageof 44

Showing results (411-420 of 436) with videos related to

Sort By:
Pageof 44
Journal of Drugs in Dermatology : JDD|December 2, 2025
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual MeetingSarah Romanelli, Gretchen D Ball, Arianna J Zhang, et al.
Seminars in Arthritis and Rheumatism|April 20, 2021
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods studySabrina Mai Nielsen, Maarten Boers, Maarten de Wit, et al.
The Journal of Rheumatology|March 18, 2014
Updating the OMERACT filter: core areas as a basis for defining core outcome setsJohn R Kirwan, Maarten Boers, Sarah Hewlett, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual MeetingArianna J Zhang, Gretchen Ball, Melissa P Zundell, et al.
The Journal of Rheumatology|March 4, 2014
Updating the OMERACT filter: implications for imaging and soluble biomarkersMaria-Antonietta D'Agostino, Maarten Boers, John Kirwan, et al.
The Journal of Rheumatology|February 17, 2019
Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA WorkshopEsi M Morgan, Jane E Munro, Jennifer Horonjeff, et al.
The Journal of Rheumatology|July 18, 2008
Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapyJorge Sánchez-Guerrero, Hilda E Fragoso-Loyo, C Michael Neuwelt, et al.
Pain|April 9, 2016
Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT systemShannon M Smith, Dagmar Amtmann, Robert L Askew, et al.
The Journal of Rheumatology|October 6, 2005
Minimal disease activity for rheumatoid arthritis: a preliminary definitionGeorge A Wells, Maarten Boers, Beverley Shea, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinementDorthe B Berthelsen, Ben Horgan, Lee Simon, et al.
Pageof 44